Literature DB >> 17823192

Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?

A A Tahrani1, G I Varughese, J H Scarpello, F W F Hanna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17823192      PMCID： PMC1971167          DOI： 10.1136/bmj.39255.669444.AE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  19 in total

1.  Frequency of inappropriate metformin prescriptions.

Authors:  Cheryl Horlen; Robb Malone; Betsy Bryant; Betty Dennis; Tim Carey; Mike Pignone; Russell Rothman
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

2.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

Review 3.  Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

Authors:  S Salpeter; E Greyber; G Pasternak; E Salpeter
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

4.  Contraindications to metformin therapy in patients with NIDDM.

Authors:  T V Sulkin; D Bosman; A J Krentz
Journal:  Diabetes Care       Date:  1997-06       Impact factor: 19.112

5.  Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.

Authors:  Jeffrey A Johnson; Sumit R Majumdar; Scot H Simpson; Ellen L Toth
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

6.  Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy.

Authors:  Amy T Calabrese; Kim C Coley; Stacey V DaPos; Dennis Swanson; R Harsha Rao
Journal:  Arch Intern Med       Date:  2002-02-25

7.  The incidence of congestive heart failure in type 2 diabetes: an update.

Authors:  Gregory A Nichols; Christina M Gullion; Carol E Koro; Sara A Ephross; Jonathan B Brown
Journal:  Diabetes Care       Date:  2004-08       Impact factor: 19.112

8.  Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study.

Authors:  Finlay A McAlister; Justin Ezekowitz; Marcello Tonelli; Paul W Armstrong
Journal:  Circulation       Date:  2004-02-09       Impact factor: 29.690

9.  Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure.

Authors:  Ida Gustafsson; Bente Brendorp; Marie Seibaek; Hans Burchardt; Per Hildebrandt; Lars Køber; Christian Torp-Pedersen
Journal:  J Am Coll Cardiol       Date:  2004-03-03       Impact factor: 24.094

Review 10.  Metformin and lactic acidosis: cause or coincidence? A review of case reports.

Authors:  A M E Stades; J T Heikens; D W Erkelens; F Holleman; J B L Hoekstra
Journal:  J Intern Med       Date:  2004-02       Impact factor: 8.989
View more
  38 in total

1.  Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Journal:  Diabetologia       Date:  2012-04-20       Impact factor: 10.122

2.  Educational needs for improving self-care in heart failure patients with diabetes.

Authors:  EunSeok Cha; Patricia C Clark; Carolyn Miller Reilly; Melinda Higgins; Maureen Lobb; Andrew L Smith; Sandra B Dunbar
Journal:  Diabetes Educ       Date:  2012-06-20       Impact factor: 2.140

3.  Impact of Japanese regulatory action on metformin-associated lactic acidosis in type II diabetes patients.

Authors:  Tadaaki Hanatani; Kimie Sai; Masahiro Tohkin; Katsunori Segawa; Yoshiro Saito
Journal:  Int J Clin Pharm       Date:  2015-03-31

4.  The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of Pathogenesis.

Authors:  Janna K Duong; Timothy J Furlong; Darren M Roberts; Garry G Graham; Jerry R Greenfield; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

5.  Use of Metformin in Patients with Kidney and Cardiovascular Diseases.

Authors:  David Klachko; Adam Whaley-Connell
Journal:  Cardiorenal Med       Date:  2011-04-14       Impact factor: 2.041

Review 6.  Diabetic cardiomyopathy: bench to bedside.

Authors:  Joel D Schilling; Douglas L Mann
Journal:  Heart Fail Clin       Date:  2012-08-09       Impact factor: 3.179

7.  Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes.

Authors:  Digish D Shah; Gregg C Fonarow; Tamara B Horwich
Journal:  J Card Fail       Date:  2009-11-14       Impact factor: 5.712

Review 8.  Postburn Hypermetabolism: Past, Present, and Future.

Authors:  Marc G Jeschke
Journal:  J Burn Care Res       Date:  2016 Mar-Apr       Impact factor: 1.845

9.  Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study.

Authors:  C Andersson; J B Olesen; P R Hansen; P Weeke; M L Norgaard; C H Jørgensen; T Lange; S Z Abildstrøm; T K Schramm; A Vaag; L Køber; C Torp-Pedersen; G H Gislason
Journal:  Diabetologia       Date:  2010-09-14       Impact factor: 10.122

10.  Association Between Preoperative Metformin Exposure and Postoperative Outcomes in Adults With Type 2 Diabetes.

Authors:  Katherine M Reitz; Oscar C Marroquin; Mazen S Zenati; Jason Kennedy; Mary Korytkowski; Edith Tzeng; Stephen Koscum; David Newhouse; Ricardo Martinez Garcia; Jennifer Vates; Timothy R Billiar; Brian S Zuckerbraun; Richard L Simmons; Stephen Shapiro; Christopher W Seymour; Derek C Angus; Matthew R Rosengart; Matthew D Neal
Journal:  JAMA Surg       Date:  2020-06-17       Impact factor: 14.766
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.